KCT0000263招募中未知
Single dose open-label comparative pharmacokinetic study to assess the pharmacokinetic characteristics of Irbesartan and Atorvastatin between Irbesartan/Atorvastatin combination tablet and coadministration of Irbesartan and Atorvastatin tablets in healthy male subjects : Irbesartan 150mg and Atorvastatin 20mg
Hanmi Pharm0 个研究点目标入组 52 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 45(Year)（—）
- 性别
- Male
入选标准
- •Age between 20 and 45
- •weight : over 45kg and in the range of ±20% of IBW
- •Have to give their consent to participating clinical trial by oneself
排除标准
- •Has a medical history of hypersensitivity to atorvastatin or irbesartan
- •severe Hypotension
- •Not eligible for subject in health examination
研究者
相似试验
已完成
不适用
Bio availability study of Mangiferin from polyherbal formulatioCTRI/2014/01/004271SRM University10
尚未招募
不适用
Bio availability study of Berberine in Manasamitra Vatakam: An ayurvedic herbomineral formulatioCTRI/2020/02/023267SRM Institute of Science and Technology
进行中（未招募）
不适用
Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia AHemophilia AEUCTR2015-003685-88-Outside-EU/EEAPfizer Inc.13
进行中（未招募）
不适用
A single dose study of BeneFIX (nonacog alfa, recombinant factor IX) in male Chinese subjects with haemophilia B.EUCTR2015-003027-61-Outside-EU/EEAPfizer Inc.12
进行中（未招募）
不适用
An open label, single dose, pharmacokinetic study of oromucosal midazolam administered to children from 3 months to less than 18 years undergoing routine elective surgery - Midazolam PKIn the context of the trial, the IMP is to be used as anaesthetic premedication in children undergoing elective routine surgery.(The medical condition for marketing is acute seizures in children aged 3 months - <18 years.)MedDRA version: 9.1Level: LLTClassification code 10058073Term: Anaesthetic premedicationEUCTR2009-012808-11-DETherakind Limited75